SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-16-000646
Filing Date
2016-11-14
Accepted
2016-11-14 17:23:33
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xenetic_10q-093016.htm 10-Q 303488
2 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 10960
3 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 10951
4 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 3812
  Complete submission text file 0001683168-16-000646.txt   1746679

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbio-20160930.xml EX-101.INS 210914
6 XBRL SCHEMA FILE xbio-20160930.xsd EX-101.SCH 23918
7 XBRL CALCULATION FILE xbio-20160930_cal.xml EX-101.CAL 42256
8 XBRL DEFINITION FILE xbio-20160930_def.xml EX-101.DEF 63682
9 XBRL LABEL FILE xbio-20160930_lab.xml EX-101.LAB 169076
10 XBRL PRESENTATION FILE xbio-20160930_pre.xml EX-101.PRE 132521
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 161995992
SIC: 2834 Pharmaceutical Preparations